Position
Quantbot Technologies LP in Enliven Therapeutics, Inc.
Back to the book · All holders of ELVN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $42.1K$15.40 → $39.20
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.77K | $27.3K | — | — | — | 0.0% |
| Q1 2026 | 10.7K | $419.9K | $39.20 | $42.1K | $350.5K | 0.0% |